Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net earnings/(loss)	$ 1,326	$ 620
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	581	524
Impairments and (gain)/loss on disposal of assets, net	(15)	626
Impairments and loss on sale of other investments	(2)	0
Share-based compensation	91	88
Provision for bad debts	41	28
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
Increase in trade receivables	(367)	(223)
Increase in inventories	(1,209)	(1,258)
Increase in accounts payable	954	2,118
Other accrued liabilities and operating items, net	(534)	(843)
Net cash provided by operating activities	870	1,680
Cash flows from investing activities:
Acquisition of subsidiaries, net of cash acquired	3,855	1,192
Proceeds from divestitures, net of cash sold	2	9
Additions to property and equipment	(315)	(318)
Proceeds from disposal of property and equipment	3	10
Purchases of investments	(6)	(3)
Proceeds from investments	7	1
Proceeds from net investment hedge terminations	2	28
Payments to Acquire Restricted Certificates of Deposit	0	550
Proceeds from short-term investment in time deposit	200	0
Net cash used in investing activities	(3,962)	(2,015)
Cash flows from financing activities:
Proceeds from long-term obligations, net of issuance costs	2,869	1,139
Reduction of long-term obligations	(434)	(23)
Net tax proceeds/(withholding) from share-based compensation	(12)	23
Dividends on common shares	(374)	(377)
Purchase of treasury shares, net	(765)	(750)
Net cash provided by financing activities	1,284	12
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	1	(7)
Net decrease in cash and equivalents	(1,807)	(330)
Cash and equivalents at beginning of period	5,133	4,076
Cash and equivalents at end of period	$ 3,326	$ 3,746